MA52365A - Composés et leurs utilisations - Google Patents
Composés et leurs utilisationsInfo
- Publication number
- MA52365A MA52365A MA052365A MA52365A MA52365A MA 52365 A MA52365 A MA 52365A MA 052365 A MA052365 A MA 052365A MA 52365 A MA52365 A MA 52365A MA 52365 A MA52365 A MA 52365A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862662673P | 2018-04-25 | 2018-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52365A true MA52365A (fr) | 2021-03-03 |
Family
ID=68290767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052365A MA52365A (fr) | 2018-04-25 | 2019-04-24 | Composés et leurs utilisations |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10919885B2 (fr) |
| EP (1) | EP3784234A1 (fr) |
| JP (1) | JP2021522253A (fr) |
| CN (1) | CN112566636A (fr) |
| MA (1) | MA52365A (fr) |
| WO (1) | WO2019209962A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3529245A4 (fr) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | Composés et utilisations de ces derniers |
| MA47212A (fr) | 2017-01-06 | 2019-11-13 | Yumanity Therapeutics Inc | Méthodes de traitement de troubles neurologiques |
| WO2019084157A1 (fr) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Composés et utilisations de ces composés |
| ES3043183T3 (en) | 2018-03-23 | 2025-11-25 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| KR20210028144A (ko) | 2018-04-06 | 2021-03-11 | 블랙 벨트 티엑스 리미티드 | Atf6 저해제 및 그의 용도 |
| MA54829A (fr) | 2019-01-24 | 2021-12-01 | Yumanity Therapeutics Inc | Composés et leurs utilisations |
| KR20220087464A (ko) * | 2019-10-09 | 2022-06-24 | 프락시스 바이오테크 엘엘씨 | Atf6 조정제 및 그의 용도 |
| IL291963B1 (en) * | 2019-10-09 | 2026-08-01 | Praxis Biotech LLC | ATF6 modulators and their uses |
| US20220406429A1 (en) * | 2019-11-04 | 2022-12-22 | The Regents Of The University Of California | Artificial Intelligence Enabled Control of Hemodynamics in Surgery Patients |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| PE20231372A1 (es) | 2020-09-03 | 2023-09-07 | Hoffmann La Roche | Compuestos heterociclicos |
| AU2022260537A1 (en) * | 2021-04-23 | 2023-09-21 | F. Hoffmann-La Roche Ag | Heterocyclic compounds |
| AR125954A1 (es) * | 2021-05-21 | 2023-08-30 | Basf Se | Uso de compuestos de etinilpiridina como inhibidores de nitrificación |
| HRP20251564T1 (hr) | 2022-05-19 | 2026-01-30 | Astrazeneca Ab | Amidni heteroaromatski spojevi korisni u liječenju bolesti jetre |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003264018A1 (en) | 2002-08-09 | 2004-02-25 | Astrazeneca Ab | Compounds having an activity at metabotropic glutamate receptors |
| US8207147B2 (en) | 2003-12-24 | 2012-06-26 | Prosidion Limited | Heterocyclic derivatives as GPCR receptor agonists |
| ES2325836T3 (es) | 2004-07-26 | 2009-09-21 | Merck Serono Sa | Derivados de la n.hidroxiamida y uso de los mismos. |
| EP2316458A1 (fr) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Derives de pyridazine destines a l'inhibition du desaturase-coa-stearoyl de l'humain |
| US7767677B2 (en) | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| EP1902051A1 (fr) | 2005-06-09 | 2008-03-26 | Merck Frosst Canada Ltd. | Derives d'azacyclohexane comme inhibiteurs de la stearoyl-coenzyme a delta-9 desaturase |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| WO2007143823A1 (fr) | 2006-06-12 | 2007-12-21 | Merck Frosst Canada Ltd. | Dérivés d'azétidine comme inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase |
| AU2007336238A1 (en) | 2006-12-20 | 2008-06-26 | Novartis Ag | 2-substituted 5-membered heterocycles as SCD inhibitors |
| ES2499018T3 (es) | 2007-09-20 | 2014-09-26 | Irm Llc | Compuestos y composiciones como moduladores de la actividad de GPR119 |
| GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
| AU2008345225A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009117676A2 (fr) | 2008-03-20 | 2009-09-24 | Forest Laboratories Holdings Limited | Nouveaux dérivés de pipéridine servant d'inhibiteurs de stéaroyle-coa-désaturase |
| TWI434842B (zh) | 2008-07-14 | 2014-04-21 | Astellas Pharma Inc | Azole compounds |
| WO2010022055A2 (fr) | 2008-08-20 | 2010-02-25 | Amgen Inc. | Inhibiteurs de canaux sodiques sensibles au potentiel |
| WO2010039186A2 (fr) | 2008-09-23 | 2010-04-08 | Renovis, Inc. | Composés utiles en tant que modulateurs de la faah et leurs utilisations |
| US20120010186A1 (en) | 2009-03-23 | 2012-01-12 | Merck Frosst Canada Ltd. | Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| WO2011079274A1 (fr) | 2009-12-23 | 2011-06-30 | Jasco Pharmaceuticals, LLC | Inhibiteurs de l'aminopyrimidine kinase |
| CN103930424A (zh) | 2011-09-01 | 2014-07-16 | Irm责任有限公司 | 作为c-Kit激酶抑制剂的化合物和组合物 |
| US9358250B2 (en) | 2011-10-15 | 2016-06-07 | Genentech, Inc. | Methods of using SCD1 antagonists |
| WO2013130625A1 (fr) | 2012-02-27 | 2013-09-06 | Basil Rigas | Dérivés de phospho-ester et leurs utilisations |
| BR112015007516A2 (pt) | 2012-10-10 | 2017-07-04 | Actelion Pharmaceuticals Ltd | antagonistas do receptor de orexina que são derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)- pirrolidin-1-il]-metanona |
| CN107249583B (zh) * | 2015-02-09 | 2021-05-07 | 国立大学法人冈山大学 | 乳酸脱氢酶抑制剂以及含有该抑制剂的抗癫痫剂 |
| EP3529245A4 (fr) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | Composés et utilisations de ces derniers |
-
2019
- 2019-04-24 CN CN201980042740.2A patent/CN112566636A/zh active Pending
- 2019-04-24 JP JP2020559520A patent/JP2021522253A/ja active Pending
- 2019-04-24 US US16/393,183 patent/US10919885B2/en active Active
- 2019-04-24 EP EP19792116.6A patent/EP3784234A1/fr not_active Withdrawn
- 2019-04-24 WO PCT/US2019/028928 patent/WO2019209962A1/fr not_active Ceased
- 2019-04-24 MA MA052365A patent/MA52365A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10919885B2 (en) | 2021-02-16 |
| JP2021522253A (ja) | 2021-08-30 |
| EP3784234A1 (fr) | 2021-03-03 |
| WO2019209962A8 (fr) | 2020-04-09 |
| WO2019209962A1 (fr) | 2019-10-31 |
| CN112566636A (zh) | 2021-03-26 |
| US20190330198A1 (en) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3917529A4 (fr) | Composés et leurs utilisations | |
| EP3917527A4 (fr) | Composés et leurs utilisations | |
| MA50256A (fr) | Composés de pyrazolopyrimidinone et leurs utilisations | |
| EP3768269A4 (fr) | Composés et leurs utilisations | |
| EP3694861A4 (fr) | Composés hétérocycliques et leurs utilisations | |
| MA55385A (fr) | Composés et leurs utilisations | |
| EP3787607C0 (fr) | Compositions de caroténoïdes et leurs utilisations | |
| EP3849983A4 (fr) | Composés de triazolo-pyrimidine et leurs utilisations | |
| EP3810182A4 (fr) | Néoantigènes et leurs utilisations | |
| EP3658170A4 (fr) | Composés abt universels et leurs utilisations | |
| MA50618A (fr) | Polyrhérapies et leurs utilisations | |
| EP3337486A4 (fr) | Composés deutérés et leurs utilisations | |
| EP3649142A4 (fr) | Composés comprenant un lieur clivable et leurs utilisations | |
| MA43205A (fr) | Composés pyy sélectifs et leurs utilisations | |
| EP3790883A4 (fr) | Composés hétéroaryles et leurs utilisations | |
| EP3902530A4 (fr) | Nanovaccins polymères et leurs utilisations | |
| EP3846807A4 (fr) | Composés d'imidazoquinoléine et leurs utilisations | |
| EP3853216A4 (fr) | Composés substitués par pyridinyle et leurs utilisations | |
| EP3880194A4 (fr) | Composés deutérés, compositions et utilisations | |
| EP4093768A4 (fr) | Constructions cal-t et leurs utilisations | |
| EP3838900A4 (fr) | Composés de 3-aryloxy-3-aryl-propylamine et utilisations associées | |
| EP3914593A4 (fr) | Composés et leurs utilisations | |
| EP3856741A4 (fr) | Composés polymorphes et leurs utilisations | |
| EP3450444A4 (fr) | Composés de type crocine et utilisations correspondantes | |
| MA48956A (fr) | Composés mic-1 et utilisations associées |